GT Biopharma Announces Preclinical Results For Its ROR1 TriKE™ As A Treatment For Prostate Cancer
TheStreet.com· 18 hours agoBEVERLY HILLS, Calif., March 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. GTBP, a clinical stage biopharmaceutical company focused on disruptive, target-directed
Predicting success in therapy with individualized cancer models
Medical Xpress· 14 hours agoIn the EU alone, 78,800 men died of prostate cancer last year. While tumors discovered at an early stage can often be completely removed by surgery and ...
Compound isolated from sea sponge fights cancer cells
Medical News Today· 2 days agoScientists believe novel chemicals with the potential to cure human illness may be found in the...
AI System Can Sniff Out Disease as Well as Dogs Do
Scientific American· 5 days agoIn a study published in February in PLOS ONE, a multinational team reported an AI-powered system that is as accurate as trained dogs at correctly identifying cases of prostate
$1m grant funds research on potential new RX for prostate cancer
EurekAlert!· 6 days agoDr. Koul is also a research scientist at the New Orleans VA Medical Center.
Austhera BioSciences, Inc. to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by...
VentureBeat· 9 hours agoAusthera BioSciences, Inc. today announced that Edward Rudnic, CEO and David Snyder, CFO will...
INOVIO To Present At Upcoming Investor Conferences In March
TheStreet.com· 5 days agoLive and archived versions of the virtual presentations will be available through the INOVIO Investor Relations Events page and may be accessed by visiting INOVIO's website at http://ir.inovio.com ...
DNA databases are too white, so genetics doesn’t help everyone. How do we fix that?
Science News· 5 days agoIt’s been two decades since the Human Genome Project first unveiled a rough draft of our genetic...
The amazing promise of artificial intelligence in health care
Medical Xpress· 14 hours agoArtificial intelligence can already scan images of the eye to assess patients for diabetic...
Epizyme Outlines Clinical Progress, TAZVERIK Development Strategy And Pipeline Priorities During...
TheStreet.com· 7 days agoEpizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, hosted a call today outlining the Company's ...
Yahoo Web Search
Top News Videos for prostate cancer, cell
04:15Surgeons can target cancerous tissue using NanoKnife
WBAL - Baltimore Videos via Yahoo News
· 2 months agoTrending Now
